15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer

Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports exami...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2005-02, Vol.280 (5), p.3217-3223
Hauptverfasser: Backlund, Michael G., Mann, Jason R., Holla, Vijaykumar R., Buchanan, F. Gregory, Tai, Hsin-Hsiung, Musiek, Erik S., Milne, Ginger L., Katkuri, Sharada, DuBois, Raymond N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3223
container_issue 5
container_start_page 3217
container_title The Journal of biological chemistry
container_volume 280
creator Backlund, Michael G.
Mann, Jason R.
Holla, Vijaykumar R.
Buchanan, F. Gregory
Tai, Hsin-Hsiung
Musiek, Erik S.
Milne, Ginger L.
Katkuri, Sharada
DuBois, Raymond N.
description Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.
doi_str_mv 10.1074/jbc.M411221200
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1847633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820761831</els_id><sourcerecordid>67405180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxS0EoqHl2mO16oHbhvHXrveCVKVAKwVxoRI3y7Fnd11t1sHepOS_x1EiCgeEL5Y8P795M4-QSwpzCrV4_7iy8y-CUsYoA3hBZhQUL7mk31-SGQCjZcOkOiNvUnqEfERDX5MzKqVgFTQzsqSyvNu7GH7uNzGkyXSDGZ0fi1vsD88djiZhcZ-K2_A0lhG77WAmdEVGFmEIEe1khmJhRovxgrxqzZDw7ek-Jw-fPn5b3JXLr5_vFzfL0opGTqVFxZxsLSjHkBmrGELL0aJxlahYy2vDK44NSJpN2kw2VWU55dAYy4Xg5-TDUXezXa3RWRynaAa9iX5t4l4H4_XfldH3ugs7TZWoK86zwLuTQAw_tpgmvfbJ4pBnx7BNuqpFbq7gvyCtOQgu6wzOj6DNW0wR299uKOhDUjonpZ-Tyh-u_pzhGT9Fk4HrI9D7rn_yEfXKB9vjWjMFWmrO6KGtOkKY173zGHWyHnMWzh-S0S74fxn4BUkQriU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17304357</pqid></control><display><type>article</type><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</creator><creatorcontrib>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</creatorcontrib><description>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M411221200</identifier><identifier>PMID: 15542609</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Colon - enzymology ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - physiopathology ; Cyclooxygenase 2 ; Dinoprostone - metabolism ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Humans ; Hydroxyprostaglandin Dehydrogenases - genetics ; Hydroxyprostaglandin Dehydrogenases - metabolism ; Membrane Proteins ; Mice ; Mice, Inbred C57BL ; Mice, Mutant Strains ; Prostaglandin-Endoperoxide Synthases - metabolism ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 2005-02, Vol.280 (5), p.3217-3223</ispartof><rights>2005 © 2005 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</citedby><cites>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847633/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847633/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15542609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Backlund, Michael G.</creatorcontrib><creatorcontrib>Mann, Jason R.</creatorcontrib><creatorcontrib>Holla, Vijaykumar R.</creatorcontrib><creatorcontrib>Buchanan, F. Gregory</creatorcontrib><creatorcontrib>Tai, Hsin-Hsiung</creatorcontrib><creatorcontrib>Musiek, Erik S.</creatorcontrib><creatorcontrib>Milne, Ginger L.</creatorcontrib><creatorcontrib>Katkuri, Sharada</creatorcontrib><creatorcontrib>DuBois, Raymond N.</creatorcontrib><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</description><subject>Animals</subject><subject>Colon - enzymology</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - physiopathology</subject><subject>Cyclooxygenase 2</subject><subject>Dinoprostone - metabolism</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Hydroxyprostaglandin Dehydrogenases - genetics</subject><subject>Hydroxyprostaglandin Dehydrogenases - metabolism</subject><subject>Membrane Proteins</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Mutant Strains</subject><subject>Prostaglandin-Endoperoxide Synthases - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1vEzEQxS0EoqHl2mO16oHbhvHXrveCVKVAKwVxoRI3y7Fnd11t1sHepOS_x1EiCgeEL5Y8P795M4-QSwpzCrV4_7iy8y-CUsYoA3hBZhQUL7mk31-SGQCjZcOkOiNvUnqEfERDX5MzKqVgFTQzsqSyvNu7GH7uNzGkyXSDGZ0fi1vsD88djiZhcZ-K2_A0lhG77WAmdEVGFmEIEe1khmJhRovxgrxqzZDw7ek-Jw-fPn5b3JXLr5_vFzfL0opGTqVFxZxsLSjHkBmrGELL0aJxlahYy2vDK44NSJpN2kw2VWU55dAYy4Xg5-TDUXezXa3RWRynaAa9iX5t4l4H4_XfldH3ugs7TZWoK86zwLuTQAw_tpgmvfbJ4pBnx7BNuqpFbq7gvyCtOQgu6wzOj6DNW0wR299uKOhDUjonpZ-Tyh-u_pzhGT9Fk4HrI9D7rn_yEfXKB9vjWjMFWmrO6KGtOkKY173zGHWyHnMWzh-S0S74fxn4BUkQriU</recordid><startdate>20050204</startdate><enddate>20050204</enddate><creator>Backlund, Michael G.</creator><creator>Mann, Jason R.</creator><creator>Holla, Vijaykumar R.</creator><creator>Buchanan, F. Gregory</creator><creator>Tai, Hsin-Hsiung</creator><creator>Musiek, Erik S.</creator><creator>Milne, Ginger L.</creator><creator>Katkuri, Sharada</creator><creator>DuBois, Raymond N.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050204</creationdate><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><author>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Colon - enzymology</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - physiopathology</topic><topic>Cyclooxygenase 2</topic><topic>Dinoprostone - metabolism</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Hydroxyprostaglandin Dehydrogenases - genetics</topic><topic>Hydroxyprostaglandin Dehydrogenases - metabolism</topic><topic>Membrane Proteins</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Mutant Strains</topic><topic>Prostaglandin-Endoperoxide Synthases - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Backlund, Michael G.</creatorcontrib><creatorcontrib>Mann, Jason R.</creatorcontrib><creatorcontrib>Holla, Vijaykumar R.</creatorcontrib><creatorcontrib>Buchanan, F. Gregory</creatorcontrib><creatorcontrib>Tai, Hsin-Hsiung</creatorcontrib><creatorcontrib>Musiek, Erik S.</creatorcontrib><creatorcontrib>Milne, Ginger L.</creatorcontrib><creatorcontrib>Katkuri, Sharada</creatorcontrib><creatorcontrib>DuBois, Raymond N.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Backlund, Michael G.</au><au>Mann, Jason R.</au><au>Holla, Vijaykumar R.</au><au>Buchanan, F. Gregory</au><au>Tai, Hsin-Hsiung</au><au>Musiek, Erik S.</au><au>Milne, Ginger L.</au><au>Katkuri, Sharada</au><au>DuBois, Raymond N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2005-02-04</date><risdate>2005</risdate><volume>280</volume><issue>5</issue><spage>3217</spage><epage>3223</epage><pages>3217-3223</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15542609</pmid><doi>10.1074/jbc.M411221200</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2005-02, Vol.280 (5), p.3217-3223
issn 0021-9258
1083-351X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1847633
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Animals
Colon - enzymology
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - physiopathology
Cyclooxygenase 2
Dinoprostone - metabolism
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Hydroxyprostaglandin Dehydrogenases - genetics
Hydroxyprostaglandin Dehydrogenases - metabolism
Membrane Proteins
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Prostaglandin-Endoperoxide Synthases - metabolism
Tumor Cells, Cultured
title 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A49%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=15-Hydroxyprostaglandin%20Dehydrogenase%20Is%20Down-regulated%20in%20Colorectal%20Cancer&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Backlund,%20Michael%20G.&rft.date=2005-02-04&rft.volume=280&rft.issue=5&rft.spage=3217&rft.epage=3223&rft.pages=3217-3223&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M411221200&rft_dat=%3Cproquest_pubme%3E67405180%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17304357&rft_id=info:pmid/15542609&rft_els_id=S0021925820761831&rfr_iscdi=true